Neither Trikafta nor Alfytrek address NBD1 ... AbbVie developed under a partnership with Galapagos. Sionna said these molecules, two correctors and one potentiator, could be combined with its ...

Trikafta, made by Vertex Pharmaceuticals, is, as its name suggests, a combination of three drugs. It works for 90 percent of patients with cystic fibrosis, and will be priced at $311,000 per year.